Immunotherapy for advanced renal cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Immunotherapy for Advanced Renal Cancer." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/456003/all/Immunotherapy_for_advanced_renal_cancer.
Immunotherapy for advanced renal cancer. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. https://evidence.unboundmedicine.com/evidence/view/EBMG/456003/all/Immunotherapy_for_advanced_renal_cancer. Accessed November 6, 2024.
Immunotherapy for advanced renal cancer. (2024). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/456003/all/Immunotherapy_for_advanced_renal_cancer
Immunotherapy for Advanced Renal Cancer [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. [cited 2024 November 06]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/456003/all/Immunotherapy_for_advanced_renal_cancer.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Immunotherapy for advanced renal cancer
ID - 456003
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/456003/all/Immunotherapy_for_advanced_renal_cancer
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -